428 related articles for article (PubMed ID: 36959802)
1. Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer.
Ni R; Li Z; Li L; Peng D; Ming Y; Li L; Liu Y
Front Oncol; 2023; 13():1143798. PubMed ID: 36959802
[TBL] [Abstract][Full Text] [Related]
2. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
3. Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap.
Halama A; Suhre K
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158820
[TBL] [Abstract][Full Text] [Related]
4. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment.
Li X; Peng X; Li Y; Wei S; He G; Liu J; Li X; Yang S; Li D; Lin W; Fang J; Yang L; Li H
Cell Commun Signal; 2024 Jan; 22(1):12. PubMed ID: 38172980
[TBL] [Abstract][Full Text] [Related]
5. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
Hoerner CR; Chen VJ; Fan AC
Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
[TBL] [Abstract][Full Text] [Related]
6. Glutamine addiction and therapeutic strategies in pancreatic cancer.
Ren LL; Mao T; Meng P; Zhang L; Wei HY; Tian ZB
World J Gastrointest Oncol; 2023 Nov; 15(11):1852-1863. PubMed ID: 38077649
[TBL] [Abstract][Full Text] [Related]
7. Glutamine Addiction and Therapeutic Strategies in Lung Cancer.
Vanhove K; Derveaux E; Graulus GJ; Mesotten L; Thomeer M; Noben JP; Guedens W; Adriaensens P
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634602
[TBL] [Abstract][Full Text] [Related]
8. Exploiting the Achilles' heel of cancer: disrupting glutamine metabolism for effective cancer treatment.
Fan Y; Xue H; Li Z; Huo M; Gao H; Guan X
Front Pharmacol; 2024; 15():1345522. PubMed ID: 38510646
[TBL] [Abstract][Full Text] [Related]
9. Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review).
Zhou L; Zhang Q; Zhu Q; Zhan Y; Li Y; Huang X
Oncol Lett; 2023 Apr; 25(4):159. PubMed ID: 36936031
[TBL] [Abstract][Full Text] [Related]
10. Glutamine Metabolism in Cancer.
Li T; Copeland C; Le A
Adv Exp Med Biol; 2021; 1311():17-38. PubMed ID: 34014532
[TBL] [Abstract][Full Text] [Related]
11. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
12. Glutamine Metabolism in Cancer.
Li T; Le A
Adv Exp Med Biol; 2018; 1063():13-32. PubMed ID: 29946773
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications.
Liu N; Shi F; Yang L; Liao W; Cao Y
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188724. PubMed ID: 35314213
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.
Matés JM; Di Paola FJ; Campos-Sandoval JA; Mazurek S; Márquez J
Semin Cell Dev Biol; 2020 Feb; 98():34-43. PubMed ID: 31100352
[TBL] [Abstract][Full Text] [Related]
15. Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies.
Wang Z; Liu F; Fan N; Zhou C; Li D; Macvicar T; Dong Q; Bruns CJ; Zhao Y
Front Oncol; 2020; 10():589508. PubMed ID: 33194749
[TBL] [Abstract][Full Text] [Related]
16. A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.
Zhu Y; Li T; Ramos da Silva S; Lee JJ; Lu C; Eoh H; Jung JU; Gao SJ
mBio; 2017 Aug; 8(4):. PubMed ID: 28811348
[TBL] [Abstract][Full Text] [Related]
17. The metabolic importance of the glutaminase II pathway in normal and cancerous cells.
Dorai T; Pinto JT; Denton TT; Krasnikov BF; Cooper AJL
Anal Biochem; 2022 May; 644():114083. PubMed ID: 33352190
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity.
Xiao-Yan W; Xiao-Xia Y; Peng-Fei S; Zong-Xue Z; Xiu-Li G
Eur J Pharmacol; 2023 Feb; 940():175323. PubMed ID: 36535492
[TBL] [Abstract][Full Text] [Related]
19. Targeting Glutamine Metabolism for Cancer Treatment.
Choi YK; Park KG
Biomol Ther (Seoul); 2018 Jan; 26(1):19-28. PubMed ID: 29212303
[TBL] [Abstract][Full Text] [Related]
20. Glutamine metabolic reprogramming in hepatocellular carcinoma.
Ye Y; Yu B; Wang H; Yi F
Front Mol Biosci; 2023; 10():1242059. PubMed ID: 37635935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]